Future efforts should focus on the following: elucidating MD2’s context-specific signaling crosstalk, designing rapid CNS delivery systems, and combining MD2 inhibitors with neuroprotective agents to achieve precision stroke therapy. Here, LY96 is linked to stroke disorder.